Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127850) titled 'A Study on the Individualized Administration of Roxadustat in the Treatment of Peritoneal Dialysis Patients with Renal Anemia Based on Drug Microbiomics' on July 8.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
Condition:
Renal anemia
Intervention:
Roxadustat group (Observation group):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2023-03-24
Target Sample Size: Roxadustat group (Observation group):54;Erythropoietin group:54;
Countries of Recruitment:...